Large-format histology in diagnosing breast carcinoma

Tatjana Ivković-Kapicl; Ferenc Vicko; Dragana Djilas; Tibor Tot

doi:10.2298/VSP180515166I

Tatjana Ivković-Kapicl University of Novi Sad, Faculty of Medicine Novi Sad, Novi Sad, Serbia
Ferenc Vicko University of Novi Sad, Faculty of Medicine Novi Sad, Novi Sad, Serbia
Dragana Djilas University of Novi Sad, Faculty of Medicine Novi Sad, Novi Sad, Serbia
Tibor Tot County Hospital Falun, Pathology & Cytology Dalarna, Falun, Sweden

DOI: https://doi.org/10.2298/VSP180515166I

Keywords: breast neoplasms, histological techniques, cytodiagnosis

References

Rampaul RS, Pinder SE, Elston CW, Ellis IO. Prognostic and predictive factors in primary breast cancer and their role in pa-tient management: The Nottingham Breast Team. Eur J Surg Oncol 2001; 27(3): 229–38.

Cianfrocca M, Goldstein LJ. Prognostic and Predictive Factors in Early-Stage Breast Cancer. Oncologist 2004; 9(6): 606–16.

Ivkovic-Kapicl T, Knezevic-Usaj S, Panjkovic M, Djilas-Ivanovic D, Golubovic M. HER-2/neu overexpression in invasive ductal breast cancer: An association with other prognostic and pre-dictive factors. Arch Oncol 2007; 15(1–2): 15–8.

Ivković-Kapicl T, Knezević-Usaj S. Human epidermal growth fac-tor receptor 2 testing in breast cancer. Med Pregl 2010; 63(1–2): 69–74. (Serbian)

Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E, et al. Primary breast cancer: ESMO Clinical Prac-tice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015; 26(Suppl 5): v8–30.

Cardoso F, Costa A, Senkus E, Aapro M, André F, Barrios CH, et al. 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3). Ann Oncol 2017; 28(1): 16‒33.

Vicko F, Radovanovic Z, Ivkovic-Kapicl T, Djilas D, Lukic D, Tatic M, et al. Intraoperative digital specimen radiography in the treatment of nonpalpable breast lesions. Srp Arh Celok Lek 2017; 145(7–8): 378–81.

Tot T, Viale G, Rutgers E, Bergsten-Nordström E, Costa A. Op-timal breast cancer pathology manifesto. European Breast Cancer Council Working Group. Eur J Cancer 2015; 51(16): 2285–8.

Tot T. The Role of Large-Format Histopathology in Assessing Subgross Morphological Prognostic Parameters: A Single Insti-tution Report of 1000 Consecutive Breast Cancer Cases. Int J Breast Cancer 2012; 2012: 395415.

Djilas-Ivanovic DD, Prvulovic NP, Bogdanovic-Stojanovic DD, Ivkovic-Kapicl TV, Ivanovic VM, Golubovic A, et al. Breast MRI: intraindividual comparative study at 1.5 and 3.0T; initial ex-perience. J BUON 2012; 17(1): 65–72.

Banin Hirata BK, Oda JMM, Losi Guembarovski R, Ariza CB, Oliveira CEC de, Watanabe MAE. Molecular Markers for Breast Cancer: Prediction on Tumor Behavior. Dis Markers 2014; 2014(7418): 513158.

Ivković-Kapicl T, Panjković M, Nikolić I, Djilas-Ivanović D, Knezević-Usaj S. Expression of cytokeratins 5/6 and cytokeratin 17 in invasive breast carcinoma. Vojnosanit Pregl 2012; 69(12): 1031–8. (Serbian)

Tot T, Tabár L. The role of radiological–pathological correla-tion in diagnosing early breast cancer: the pathologist’s per-spective. Virchows Arch 2011; 458(2): 125–31.

Biesemier KW, Alexander MC. Enhancement of Mammograph-ic–Pathologic Correlation Utilizing Large Format Histology for Malignant Breast Disease. Semin Breast Dis 2005; 8(3): 152–62.

Tot T. Towards a renaissance of subgross breast morphology. Eur J Cancer2010; 46(11): 1946–8.

Jackson PA, Cook MG, Merchant W, McCormick CJ. A compari-son of large block macrosectioning and conventional tech-niques in breast pathology. Virchows Arch 1994; 425(3): 243–8.

Tucker FL. New Era Pathologic Techniques in the Diagnosis and Reporting of Breast Cancers. Semin Breast Dis 2008; 11(3): 140–7.

Foschini MP, Baldovini C, Ishikawa Y, Eusebi V. The Value of Large Sections in Surgical Pathology. Int J Breast Cancer 2012; 2012: 785947.

Tot T. Cost-benefit analysis of using large-format histology sections in routine diagnostic breast care. Breast 2010; 19(4): 284–8.

Peralta EA, Tucker FL. Preoperative Magnetic Resonance Im-aging and Large-Format Breast Pathology: Closing the Loop. J Clin Oncol 2014; 32(25): 2817–8.

Sorace J, Aberle DR, Elimam D, Lawvere S, Tawfik O, Wallace WD. Integrating pathology and radiology disciplines: an emerging opportunity? BMC Med 2012; 10(1): 100.

Tot T. Large-Format Histology, a Prerequisite for Adequate Assessment of Early Breast Carcinomas. In: Kahan Z, Tot T, editors. Breast Cancer, a Heterog Dis Entity. Dordrecht, Hei-delberg, London, New York: Springer; 2011. p. 57–88.

Tabár L, Tot T, Dean P. Breast cancer: the art and science of early detection by mammography: perception, interpretation, histopathologic correlation. Stuttgart, New York: Thieme; 2005. p. 405–38.

Tucker FL. Imaging-Assisted Large-Format Breast Pathology: Program Rationale and Development in a Nonprofit Health System in the United States. Int J Breast Cancer 2012; 2012: 171792.

Clarke GM, Eidt S, Sun L, Mawdsley G, Zubovits JT, Yaffe MJ. Whole-specimen histopathology: a method to produce whole-mount breast serial sections for 3-D digital histopathology im-aging. Histopathology 2007; 50(2): 232–42.

Foster MR, Harris L, Biesemier KW. Large Format Histology May Aid in the Detection of Unsuspected Pathologic Findings of Potential Clinical Significance: A Prospective Multiyear Single Institution Study. Int J Breast Cancer 2012; 2012: 532547.

Parolin C, Marangoni A, Laghi L, Foschi C, Ñahui Palomino RA, Calonghi N, et al. Isolation of Vaginal Lactobacilli and Charac-terization of Anti-Candida Activity. PLoS One 2015; 10(6): e0131220.

Foschini MP, Righi A, Cucchi MC, Ragazzini T, Merelli S, San-teramo B, et al. The impact of large sections and 3D technique on the study of lobular in situ and invasive carcinoma of the breast. Virchows Arch 2006; 448(3): 256–61.

Tot T. Conventional and non-conventional pathologic workup of specimens with early breast carcinomas. Mag Eur Med On-col 2011; 4(3): 163–6.

Tot T. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections. Cancer 2007; 110(11): 2551–60.

Lindquist D, Hellberg D, Tot T. Disease Extent ≥4 cm Is a Prognostic Marker of Local Recurrence in T1-2 Breast Can-cer. Patholog Res Int 2011; 2011: 860584..

Tot T. The origins of early breast carcinoma. Semin Diagn Pathol 2010; 27(1): 62–8.

Tot T. The Theory of the Sick Breast Lobe and the Possible Consequences. Int J Surg Pathol 2007; 15(4): 369–75.

Pekar G, Hofmeyer S, Tabár L, Tarján M, Chen TH, Yen AM, et al. Multifocal breast cancer documented in large-format his-tology sections. Cancer 2013; 119(6): 1132–9.

Deurloo EE, Klein Zeggelink WF, Teertstra HJ, Peterse JL, Rutgers EJ, Muller SH, et al. Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complementary value for subgroups of patients. Eur Radiol 2006; 16(3): 692–701.

Tot T. The metastatic capacity of multifocal breast carcinomas: extensive tumors versus tumors of limited extent. Hum Pathol 2009; 40(2): 199–205.

Tot T, Gere M, Pekár G, Tarján M, Hofmeyer S, Hellberg D, et al. Breast cancer multifocality, disease extent, and survival. Hum Pathol 2011; 42(11): 1761–9.

Ibarra JA. The Value of Combined Large Format Histo-pathology Technique to Assess the Surgically Removed Breast Tissue following Neoadjuvant Chemotherapy: A Single Insti-tution Study of 40 Cases. Int J Breast Cancer 2012; 2012: 361707.

Tot T, Gere M. Radiological–Pathological Correlation in Diag-nosing Breast Carcinoma: The Role of Pathology in the Mul-timodality Era. Pathol Oncol Res 2008; 14(2): 173–8.

Hofmeyer S, Pekár G, Gere M, Tarján M, Hellberg D, Tot T. Comparison of the Subgross Distribution of the Lesions in In-vasive Ductal and Lobular Carcinomas of the Breast: A Large-Format Histology Study. Int J Breast Cancer 2012; 2012: 436141.